Citigroup’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.4K | Sell |
2,208
-4,901
| -69% | -$75.7K | ﹤0.01% | 4769 |
|
|
2025
Q4 | $145K | Buy |
7,109
+4,192
| +144% | +$73.5K | ﹤0.01% | 4142 |
|
|
2025
Q3 | $46.1K | Sell |
2,917
-31,462
| -92% | -$465K | ﹤0.01% | 4528 |
|
|
2025
Q2 | $459K | Sell |
34,379
-37,378
| -52% | -$505K | ﹤0.01% | 3677 |
|
|
2025
Q1 | $731K | Buy |
71,757
+17,334
| +32% | +$201K | ﹤0.01% | 3458 |
|
|
2024
Q4 | $862K | Buy |
54,423
+31,042
| +133% | +$1.61M | ﹤0.01% | 3468 |
|
|
2024
Q3 | $1.36M | Buy |
23,381
+10,798
| +86% | +$533K | ﹤0.01% | 3002 |
|
|
2024
Q2 | $575K | Sell |
12,583
-104,873
| -89% | -$5.64M | ﹤0.01% | 3300 |
|
|
2024
Q1 | $7.78M | Sell |
117,456
-51,935
| -31% | -$3.08M | 0.01% | 1414 |
|
|
2023
Q4 | $6.73M | Buy |
169,391
+71,282
| +73% | +$2.24M | 0.01% | 1418 |
|
|
2023
Q3 | $3.13M | Sell |
98,109
-54,738
| -36% | -$2.04M | ﹤0.01% | 1696 |
|
|
2023
Q2 | $6.14M | Sell |
152,847
-173,217
| -53% | -$7.59M | 0.01% | 1376 |
|
|
2023
Q1 | $13.9M | Sell |
326,064
-86,039
| -21% | -$4.35M | 0.02% | 985 |
|
|
2022
Q4 | $19.8M | Sell |
412,103
-64,020
| -13% | -$2.99M | 0.03% | 802 |
|
|
2022
Q3 | $17.9M | Buy |
476,123
+13,753
| +3% | +$477K | 0.03% | 831 |
|
|
2022
Q2 | $12.8M | Buy |
462,370
+454,498
| +5,774% | +$19.9M | 0.02% | 1034 |
|
|
2022
Q1 | $428K | Sell |
7,872
-24,248
| -75% | -$1.24M | ﹤0.01% | 3617 |
|
|
2021
Q4 | $1.88M | Buy |
32,120
+13,518
| +73% | +$674K | ﹤0.01% | 2677 |
|
|
2021
Q3 | $736K | Sell |
18,602
-22,942
| -55% | -$816K | ﹤0.01% | 3329 |
|
|
2021
Q2 | $1.76M | Sell |
41,544
-1,153
| -3% | -$62.5K | ﹤0.01% | 2755 |
|
|
2021
Q1 | $2.63M | Buy |
42,697
+39,391
| +1,192% | +$2.5M | ﹤0.01% | 2304 |
|
|
2020
Q4 | $233K | Buy |
3,306
+2,971
| +887% | +$187K | ﹤0.01% | 4877 |
|
|
2020
Q3 | $13K | Sell |
335
-608
| -64% | -$24.1K | ﹤0.01% | 6452 |
|
|
2020
Q2 | $35K | Buy |
+943
| New | +$29.1K | ﹤0.01% | 6227 |
|
Other funds holding KROS
NCM
VCM
O
VPM
MAP